GENEVA, Nov. 24 -- FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI (Via Venezian, 120133 Milano) filed a patent application (PCT/IB2025/055133) for "MLUC1 ANTIBODY" on May 16, 2025. With publication no. WO/2025/238612, the details related to the patent application was published on Nov 20, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): FIGINI, Mariangela (Via F. Juvara, 2620129 Milano)
Abstract: The invention concerns an antibody, the same conjugated to a cytotoxic payload, the bispecific antibody thereof, and a pharmaceutical composition comprising them, for use as a medicament. Uses in the...